WATSON 629 (Nora-BE 0.35 mg)
Generic Name: norethindrone
Pill imprint WATSON 629 has been identified as Nora-BE 0.35 mg.
Nora-Be is used in the treatment of abnormal uterine bleeding; endometriosis; amenorrhea; birth control and belongs to the drug classes contraceptives, progestins. Not for use in pregnancy. Nora-Be 0.35 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- norethindrone
- Imprint:
- WATSON 629
- Strength:
- 0.35 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Contraceptives
Progestins - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 52544-0629
- Inactive Ingredients:
- lactose
magnesium stearate
povidone
corn starch
More about Nora-Be (norethindrone)
Consumer resources
- Other brands: Camila, Aygestin, Jolivette, Ortho Micronor, More (3) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
